subject area of
- Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Academic Article
- BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38− cells, through activation of protein kinase Cβ Academic Article
- Biting into a union of oncology and metabolism through leukemic stem cells Academic Article
- Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era Academic Article
- Cardiovascular Events After Exposure to Nilotinib in Chronic Myeloid Leukemia: Long-term Follow-up Academic Article
- Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines? Academic Article
- Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study Academic Article
- Choroiditis and exudative macular detachments in a post transplant leukaemic patient: an unusual presentation of Pneumocystis jiroveci infection Academic Article
- Chromosome Abnormalities in Chronic Myeloid Leukaemia Academic Article
- Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma Academic Article
- Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib Academic Article
- Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia Academic Article
- Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocol Academic Article
- Exon-skipping in BCR/ABL is induced by ABL exon 2 Academic Article
- Expression of embryonic globins by erythroid cells in juvenile chronic myelocytic leukemia Academic Article
- Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia Academic Article
- Gender andBCR-ABLtranscript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia Academic Article
- Imatinib mesylate in children and adolescents with cancer Academic Article
- Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta-analysis Academic Article
- Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group Academic Article
- Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Academic Article
- Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: A leukemia intergroup study Academic Article
- Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial Academic Article
- Outcomes of children with chronic myeloid leukemia: A population‐based cohort study Academic Article
- Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis. Academic Article
- Response to ‘Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors’ Academic Article
- Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results Academic Article
- The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia Academic Article
- Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells Academic Article
- Treatment Outcomes in Chronic Myeloid Leukemia: Does One Size Fit All? Academic Article
- Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013 Conference Paper
- Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease Academic Article
- Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants Academic Article